They showed that the presence of factor V Leiden and prothrombin G20210A mutation were related to the central venous catheter thrombosis.18 Decousus et al. noted that antiphospholipid antibodies and acquired resistance to activated protein C predispose the cancer patients to thrombosis. This evidence concerns the gene F5 and cancer.